124 related articles for article (PubMed ID: 19202736)
1. In vitro and in vivo studies of a new sustained release formulation of morphine. Discrepancies between the in vitro release and the in vivo absorption in dogs.
Araícot A; Torres-Molina F; Saadeddin A; Cárcel-Trullols J; Alvarez-Fuentes J; Holgado A; Fernández-Arévalo M; Peris JE
Arzneimittelforschung; 2008; 58(12):647-52. PubMed ID: 19202736
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of a new sustained-release formulation of morphine.
Araico A; Saadeddin A; Torres-Molina F; Peris JE
Pharmazie; 2009 Oct; 64(10):653-5. PubMed ID: 19947167
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
Kinzler ER; Pantaleon C; Iverson M; Aigner S
Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
5. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
Gourlay GK
Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
7. The relative bioavailability of morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®) and an extended release morphine sulfate capsule formulation (KADIAN®) in healthy adults under fasting conditions.
Johnson FK; Ciric S; Boudriau S; Kisicki JC; Stauffer J
Am J Ther; 2011 Jan; 18(1):2-8. PubMed ID: 20864883
[TBL] [Abstract][Full Text] [Related]
8. The effect of food intake on the pharmacokinetics of sustained-release morphine sulfate capsules.
Kaiko RF
Clin Ther; 1997; 19(2):296-303. PubMed ID: 9152568
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic evaluations of novel oral morphine sustained release granules.
Nakamura K; Nara E; Fuse T; Akiyama Y
Biol Pharm Bull; 2007 Aug; 30(8):1456-60. PubMed ID: 17666803
[TBL] [Abstract][Full Text] [Related]
10. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
Du X; Skopp G; Aderjan R
Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
[TBL] [Abstract][Full Text] [Related]
11. Relative Oral Bioavailability of an Abuse-deterrent, Extended-release Formulation of Morphine Versus Extended-release Morphine: A 2-period, Single-dose, Randomized Crossover Study in Healthy Subjects.
Kinzler ER; Pantaleon C; Aigner S
Clin Ther; 2018 Aug; 40(8):1357-1365. PubMed ID: 30049503
[TBL] [Abstract][Full Text] [Related]
12. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence study of two morphine extended release formulations after multiple dosing in healthy volunteers.
Heinrich-Nols J; Schug BS; Evers G; Larsimont V; Elze M; Blume HH; Lee LS; Crawford F
Int J Clin Pharmacol Ther; 1999 Mar; 37(3):153-8. PubMed ID: 10190764
[TBL] [Abstract][Full Text] [Related]
14. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
15. Development of an oral sustained release drug delivery system utilizing pH-dependent swelling of carboxyvinyl polymer.
Nakamura K; Nara E; Akiyama Y
J Control Release; 2006 Apr; 111(3):309-15. PubMed ID: 16473430
[TBL] [Abstract][Full Text] [Related]
16. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
17. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
18. Morphine and metabolites plasma levels after administration of sustained release morphine in Roux-en-Y gastric bypass subjects versus matched control subjects.
Hachon L; Reis R; Labat L; Poitou C; Jacob A; Declèves X; Lloret-Linares C
Surg Obes Relat Dis; 2017 Nov; 13(11):1869-1874. PubMed ID: 28864105
[TBL] [Abstract][Full Text] [Related]
19. Effect of gallbladder contraction induced cholagogia on the pharmacokinetic profile of a sustained-release theophylline formulation.
Fuchs WS; von Nieciecki A; Molz KH; Popescu G; Weil A; Barkworth MF; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1996 Dec; 46(12):1120-6. PubMed ID: 9006785
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs.
KuKanich B; Lascelles BD; Papich MG
J Vet Pharmacol Ther; 2005 Aug; 28(4):371-6. PubMed ID: 16050817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
